Back to Search
CHARLENE SABIN, M.D.
M.D.
Developmental - Behavioral Pediatrics Physician
NPI: 1477616845Individual
Specialties, Licenses & Credentials
Developmental - Behavioral Pediatrics PhysicianPrimary
Pediatrics — Developmental - Behavioral Pediatrics
Code: 2080P0006X
MD11303(OR)
Research & Publications (20)
An audit of antiretroviral treatment use in HIV-infected patients in a London clinic: the limitations of observational databases when auditing antiretroviral treatment use.
PMID 12702128·HIV Med·2003
8-other
Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study.
PMID 12443592·Lancet·2002
8-other
Treatment comparisons in HIV infection: the benefits and limitations of observational cohort studies.
PMID 11266407·J Antimicrob Chemother·2001
8-other
Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
PMID 11471111·J Infect Dis·2001
8-other
Course of viral load throughout HIV-1 infection.
PMID 10737432·J Acquir Immune Defic Syndr·2000
8-other
Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy.
PMID 10853982·AIDS·2000
8-other
British HIV Association (BHIVA) national cohort outcomes audit of patients commencing antiretrovirals from naïve.
PMID 19490183·HIV Med·2009
8-other
Is 1 alanine transaminase >200 IU enough to define an alanine transaminase flare in HIV-infected populations? A new definition derived from a large cohort study.
PMID 19553826·J Acquir Immune Defic Syndr·2009
8-other
Should HIV therapy be started at a CD4 cell count above 350 cells/microl in asymptomatic HIV-1-infected patients?
PMID 19283914·Curr Opin Infect Dis·2009
6-review
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
PMID 19571723·AIDS·2009
4-observational
Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.
PMID 19487907·AIDS·2009
4-observational
CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK.
PMID 19336735·Haematologica·2009
8-other
HIV viremia and the development of AIDS-related lymphoma in patients treated with highly active antiretroviral therapy.
PMID 19476436·J Infect Dis·2009
8-other
Virological response to initial antiretroviral regimens containing abacavir or tenofovir.
PMID 19635022·J Infect Dis·2009
8-other
Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.
PMID 19331585·Clin Infect Dis·2009
4-observational
Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.
PMID 19668084·J Acquir Immune Defic Syndr·2009
8-other
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
PMID 19275498·Clin Infect Dis·2009
8-other
Improvements in cheek volume in lipoatrophic individuals switching away from thymidine nucleoside reverse transcriptase inhibitors.
PMID 19490181·HIV Med·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 106 SW WOODS ST
PORTLAND, OR 97201 - Phone
- (503) 282-6448
Quick Facts
- NPI
- 1477616845
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile